A Post-marketing Surveillance (PMS) Study of Safety and Effectiveness in Subjects With Tigecycline Treatment

Trial Profile

A Post-marketing Surveillance (PMS) Study of Safety and Effectiveness in Subjects With Tigecycline Treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections; Skin and soft tissue infections
  • Focus Adverse reactions
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 08 Jun 2015 Planned number of patients changed from 742 to 3000 as reported by ClinicalTrials.gov record.
    • 08 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Jul 2014 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top